AlphaYou
Overview
8 funds hold it, insiders have been net selling, and 12 straight earnings beats.
Key stats
Sep 7- Open
- $608.58
- 52-wk high
- $647.00
- High
- $615.74
- 52-wk low
- $434.83
- Low
- $605.53
- Prev close
- $618.43
- Mkt cap
- $226.94B
- P/E
- 33.0x
- Volume
- 1.23M
- Fwd P/E
- 22.5x
- Beta
- 0.85
- Div yield
- 0.29%
- P/S
- 4.9x
- P/B
- 4.3x
- Profit margin
- +15.0%
- Op margin
- +18.8%
- ROE
- +13.5%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 5.6% above what analysts expected.
Earnings per share
$5.71 expected
Revenue
No comparable estimate
Reports Oct 21, 2026, in 44 days
EPS expected
$6.33 to $6.56
Revenue expected
20 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $11.12B | $12.21B | $11.01B | $11.99B |
| Cost of what it sold | $6.47B | $7.58B | $6.53B | $7.05B |
| Gross profit | $4.65B | $4.64B | $4.48B | $4.94B |
| What it spent | ||||
| Research and development | $347.0M | $357.0M | $336.0M | $364.0M |
| Sales and admin | $2.16B | $1.98B | $2.18B | $1.91B |
| Other operating costs | $203.0M | — | $96.0M | $583.0M |
| Total operating expenses | $2.71B | $2.33B | $2.61B | $2.86B |
| What was left | ||||
| Operating profit | $1.94B | $2.30B | $1.86B | $2.09B |
| Interest on debt | $347.0M | $365.0M | $354.0M | $401.0M |
| Profit before tax | $1.83B | $2.12B | $1.73B | $1.92B |
| Tax | $207.0M | $153.0M | $70.0M | $167.0M |
| Net profit | $1.62B | $1.98B | $1.65B | $1.74B |
| EBITDA | $2.84B | $3.21B | $2.31B | $2.57B |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Baird Adjusts Price Target on Thermo Fisher Scientific to $686 From $652, Keeps Outperform Rating
BullishSep 3SBC Medical to Participate in Several Upcoming Investor Conferences in September 2026
NeutralSep 3PACB Cuts 2026 Outlook as Clinical Adoption Faces Its Crucial Test
NeutralSep 3Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market
BullishSep 2Society for Science Announces Top 300 for the 2026 Thermo Fisher Scientific Junior Innovators Challenge
BullishSep 2Thermo Fisher (NYSE:TMO): Is the Rally Running Out of Room?
NeutralSep 2Thermo Fisher Launches Microplate Reader for Routine Absorbance Assays
BullishSep 2Thermo Fisher Scientific Launches Multiskan™ Ease Absorbance Microplate Reader to Help Simplify Protein, Cell and Microbial Analysis
BullishSep 2
Macro
30 macro signals shaping TMO right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results